Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Amneal Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was $6.07. Amneal Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 307 Mil. Therefore, Amneal Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was $1,861 Mil.
Amneal Pharmaceuticals's quarterly market cap
increased
from Jun. 2023 ($478 Mil) to Sep. 2023 ($651 Mil) and
increased
from Sep. 2023 ($651 Mil) to Dec. 2023 ($1,861 Mil).
Amneal Pharmaceuticals's annual market cap
declined
from Dec. 2021 ($716 Mil) to Dec. 2022 ($301 Mil) but then
increased
from Dec. 2022 ($301 Mil) to Dec. 2023 ($1,861 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Amneal Pharmaceuticals's Enterprise Value for Today is $4,314 Mil.
Amneal Pharmaceuticals Market Cap Historical Data
The historical data trend for Amneal Pharmaceuticals's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Amneal Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amneal Pharmaceuticals Market Cap Distribution
For the Drug Manufacturers industry and Healthcare sector, Amneal Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Amneal Pharmaceuticals's Market Cap falls into.
Amneal Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Amneal Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amneal Pharmaceuticals (NAS:AMRX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Amneal Pharmaceuticals Market Cap Related Terms
Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Amneal Pharmaceuticals (Amneal Pharmaceuticals) Business Description
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMRX has been successfully added to your 